• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类去分化脂肪肉瘤的细胞起源和克隆进化。

Cellular origin and clonal evolution of human dedifferentiated liposarcoma.

机构信息

INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, Institut Curie Research Center, Paris, France.

Department of Translational Research, Institut Curie Research Center, Paris, France.

出版信息

Nat Commun. 2024 Sep 12;15(1):7941. doi: 10.1038/s41467-024-52067-1.

DOI:10.1038/s41467-024-52067-1
PMID:39266532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393420/
Abstract

Dedifferentiated liposarcoma (DDLPS) is the most frequent high-grade soft tissue sarcoma subtype. It is characterized by a component of undifferentiated tumor cells coexisting with a component of well-differentiated adipocytic tumor cells. Both dedifferentiated (DD) and well-differentiated (WD) components exhibit MDM2 amplification, however their cellular origin remains elusive. Using single-cell RNA sequencing, DNA sequencing, in situ multiplex immunofluorescence and functional assays in paired WD and DD components from primary DDLPS tumors, we characterize the cellular heterogeneity of DDLPS tumor and micro-environment. We identify a population of tumor adipocyte stem cells (ASC) showing striking similarities with adipocyte stromal progenitors found in white adipose tissue. We show that tumor ASC harbor the ancestral genomic alterations of WD and DD components, suggesting that both derive from these progenitors following clonal evolution. Last, we show that DD tumor cells keep important biological properties of ASC including pluripotency and that their adipogenic properties are inhibited by a TGF-β-high immunosuppressive tumor micro-environment.

摘要

去分化脂肪肉瘤(DDLPS)是最常见的高级软组织肉瘤亚型。它的特征是存在未分化的肿瘤细胞成分和分化良好的脂肪性肿瘤细胞成分。去分化(DD)和分化良好(WD)成分均表现出 MDM2 扩增,但它们的细胞起源仍不清楚。通过对原发性 DDLPS 肿瘤的 WD 和 DD 成分进行单细胞 RNA 测序、DNA 测序、原位多重免疫荧光和功能检测,我们对 DDLPS 肿瘤及其微环境的细胞异质性进行了描述。我们鉴定出一群肿瘤脂肪细胞干细胞(ASC),它们与在白色脂肪组织中发现的脂肪基质祖细胞具有惊人的相似性。我们表明,肿瘤 ASC 具有 WD 和 DD 成分的原始基因组改变,这表明它们都来源于这些祖细胞的克隆进化。最后,我们表明 DD 肿瘤细胞保持了 ASC 的重要生物学特性,包括多能性,并且它们的成脂特性被 TGF-β 高免疫抑制性肿瘤微环境所抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/a7a56cd94c63/41467_2024_52067_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/bb9893fdd59d/41467_2024_52067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/24b965f3f8b8/41467_2024_52067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/e57f69f560e9/41467_2024_52067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/0abcda7a1f3e/41467_2024_52067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/45e9e33e2fdb/41467_2024_52067_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/ee846c7cecfb/41467_2024_52067_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/a7a56cd94c63/41467_2024_52067_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/bb9893fdd59d/41467_2024_52067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/24b965f3f8b8/41467_2024_52067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/e57f69f560e9/41467_2024_52067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/0abcda7a1f3e/41467_2024_52067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/45e9e33e2fdb/41467_2024_52067_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/ee846c7cecfb/41467_2024_52067_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d344/11393420/a7a56cd94c63/41467_2024_52067_Fig7_HTML.jpg

相似文献

1
Cellular origin and clonal evolution of human dedifferentiated liposarcoma.人类去分化脂肪肉瘤的细胞起源和克隆进化。
Nat Commun. 2024 Sep 12;15(1):7941. doi: 10.1038/s41467-024-52067-1.
2
GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.富含Gli1 的去分化/未分化脂肪肉瘤中Gli1 共扩增:92 例病例的临床病理和分子分析。
Mod Pathol. 2024 Jun;37(6):100494. doi: 10.1016/j.modpat.2024.100494. Epub 2024 Apr 15.
3
Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?外周部单纯未分化多形性肉瘤伴 MDM2 扩增是去分化脂肪肉瘤吗?
Am J Surg Pathol. 2014 Mar;38(3):293-304. doi: 10.1097/PAS.0000000000000131.
4
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.一种用于研究高分化和去分化脂肪肉瘤的实验模型;靶向酪氨酸激酶受体的失调。
Lab Invest. 2011 Mar;91(3):392-403. doi: 10.1038/labinvest.2010.185. Epub 2010 Nov 8.
5
Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.转化的人间质干细胞中 MDM2 和 CDK4 的共表达导致具有去分化脂肪肉瘤样形态的高级别肉瘤。
Lab Invest. 2019 Sep;99(9):1309-1320. doi: 10.1038/s41374-019-0263-4. Epub 2019 Jun 3.
6
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma.去分化脂肪肉瘤中去分化成分与高分化成分的早期分离及平行克隆选择
Neoplasia. 2025 Jan;59:101074. doi: 10.1016/j.neo.2024.101074. Epub 2024 Nov 25.
7
Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.非典型脂肪瘤样肿瘤/高分化脂肪肉瘤与去分化脂肪肉瘤的鉴别诊断:p16联合MDM2和CDK4免疫组化的应用价值
Hum Pathol. 2017 Jan;59:34-40. doi: 10.1016/j.humpath.2016.08.009. Epub 2016 Sep 3.
8
Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes.源自去分化脂肪肉瘤细胞外囊泡诱导前脂肪细胞产生 MMP2。
Cancer Res. 2019 Oct 1;79(19):4911-4922. doi: 10.1158/0008-5472.CAN-19-0203. Epub 2019 Aug 6.
9
Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.与配对的高分化脂肪肉瘤相比,去分化脂肪肉瘤的基因组分析显示出更高的基因组复杂性和共同起源。
Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). doi: 10.1101/mcs.a002386. Print 2018 Apr.
10
Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.55例去分化脂肪肉瘤患者去分化组织学分级与临床结局的相关性
Hum Pathol. 2017 Aug;66:86-92. doi: 10.1016/j.humpath.2017.02.015. Epub 2017 Mar 12.

引用本文的文献

1
Deep Introspection Regarding Cumulative Prognostic Factors in Liposarcoma and Atypical Lipomatous Tumor.关于脂肪肉瘤和非典型脂肪瘤性肿瘤累积预后因素的深入思考
Medicina (Kaunas). 2025 Aug 8;61(8):1431. doi: 10.3390/medicina61081431.
2
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry.11132例脂肪肉瘤患者的临床表现、治疗及预后:一项基于NETSARC+注册研究的人群研究
Lancet Reg Health Eur. 2025 Jul 31;57:101403. doi: 10.1016/j.lanepe.2025.101403. eCollection 2025 Oct.
3
PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma.

本文引用的文献

1
The proteomic landscape of soft tissue sarcomas.软组织肉瘤的蛋白质组学全景。
Nat Commun. 2023 Jun 29;14(1):3834. doi: 10.1038/s41467-023-39486-2.
2
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers.除了在高分化和去分化脂肪肉瘤中靶向扩增的MDM2和CDK4:从前景与临床应用到鉴定进展驱动因素。
Front Oncol. 2022 Sep 2;12:965261. doi: 10.3389/fonc.2022.965261. eCollection 2022.
3
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma.
PPARG在高分化和去分化脂肪肉瘤中调控脂肪生成分化和细胞状态可塑性。
bioRxiv. 2025 Jul 21:2025.07.16.665211. doi: 10.1101/2025.07.16.665211.
4
A Case of Gastric Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Endoscopic Morphological Changes.一例伴有内镜形态学改变的胃非典型脂肪瘤样肿瘤/高分化脂肪肉瘤
DEN Open. 2025 May 22;6(1):e70146. doi: 10.1002/deo2.70146. eCollection 2026 Apr.
5
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.代谢程序的表观遗传失调介导脂肪肉瘤细胞可塑性。
bioRxiv. 2025 Jan 24:2025.01.20.633920. doi: 10.1101/2025.01.20.633920.
6
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma.去分化脂肪肉瘤中去分化成分与高分化成分的早期分离及平行克隆选择
Neoplasia. 2025 Jan;59:101074. doi: 10.1016/j.neo.2024.101074. Epub 2024 Nov 25.
7
A metabolic crosstalk between liposarcoma and muscle sustains tumor growth.脂肪肉瘤与肌肉之间的代谢串扰维持肿瘤生长。
Nat Commun. 2024 Sep 12;15(1):7940. doi: 10.1038/s41467-024-51827-3.
单细胞分析和功能表征揭示了横纹肌肉瘤的干细胞层次结构和发育起源。
Nat Cancer. 2022 Aug;3(8):961-975. doi: 10.1038/s43018-022-00414-w. Epub 2022 Aug 18.
4
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.伴三级淋巴结构的软组织肉瘤中的帕博利珠单抗:PEMBROSARC 试验队列的 2 期研究
Nat Med. 2022 Jun;28(6):1199-1206. doi: 10.1038/s41591-022-01821-3. Epub 2022 May 26.
5
The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.成肌细胞生成程序驱动横纹肌肉瘤的克隆选择和耐药性。
Dev Cell. 2022 May 23;57(10):1226-1240.e8. doi: 10.1016/j.devcel.2022.04.003. Epub 2022 Apr 27.
6
A single-cell atlas of human and mouse white adipose tissue.人类和小鼠白色脂肪组织的单细胞图谱
Nature. 2022 Mar;603(7903):926-933. doi: 10.1038/s41586-022-04518-2. Epub 2022 Mar 16.
7
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.CD4+ T 细胞和 M2 巨噬细胞浸润预测去分化脂肪肉瘤患者的预后。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-002812.
8
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤:ESMO-EURACAN-GENTURIS诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Nov;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006. Epub 2021 Jul 22.
9
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.利用专家病理审查网络,四年间全国范围内的中间恶性肉瘤和结缔组织肿瘤的发病率。
PLoS One. 2021 Feb 25;16(2):e0246958. doi: 10.1371/journal.pone.0246958. eCollection 2021.
10
Genetic drivers and cells of origin in sarcomagenesis.肉瘤发生中的遗传驱动因素和起始细胞。
J Pathol. 2021 Jul;254(4):474-493. doi: 10.1002/path.5617. Epub 2021 Mar 18.